Journal
GASTROENTEROLOGIA Y HEPATOLOGIA
Volume 35, Issue 8, Pages 560-566Publisher
ELSEVIER ESPANA SLU
DOI: 10.1016/j.gastrohep.2012.05.007
Keywords
Thalidomide; Multiple myeloma; Drug induced liver injury
Categories
Ask authors/readers for more resources
Drug-induced liver injury (DILI) is a leading cause of liver failure and an important safety issue in drug development. Thalidomide is nowadays used for the treatment of several conditions including multiple myeloma (MM). Several adverse effects have been described but liver toxicity was seldom reported. We describe a case of thalidomide-induced hepatitis in a man treated for MM. The clinical setting and temporal association between the start of the drug and liver injury allowed the assumption of the causative role of thalidomide. As its clinical indications expand we wish to increase awareness of a new potential side effect of thalidomide. A short review on thalidomide-induced liver injury is also presented. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available